^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    epratuzumab-thorium-227 (BAY1862864)

    i
    Associations
    News
    Trials
    Company:
    Bayer
    Drug class:
    Apoptosis stimulant, CD22 modulator
    Related drugs:
    Associations
    News
    Trials